Vos Ellen O'Connor 4
4 · Modular Medical, Inc. · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
Modular Medical (MODD) Director Vos O'Connor Receives Option Award
What Happened
Vos Ellen O'Connor, a director of Modular Medical, was granted a derivative award on 2026-06-30: an option covering 250 shares. The grant was reported on a Form 4 filed 2026-07-02. No exercise price or immediate cash value is provided in the filing (listed as N/A); the award is a derivative security (option), not an open‑market purchase or sale.
Key Details
- Transaction date: 2026-06-30; Form 4 filed: 2026-07-02 (appears timely for a Form 4 filing).
- Security: Option award covering 250 shares (derivative); price and total value reported as N/A.
- Vesting/Exercisability: Per footnote, the option was granted under the issuer’s Outside Director Compensation Plan and was fully vested and exercisable on the grant date.
- Ownership reporting: The filing’s Column 9 reports total beneficial ownership of the class of derivative security; options with different exercise prices or vesting terms are reported separately (see footnote).
- No indication in the filing that the option was exercised or that shares were sold immediately.
Context
This is a compensation-related option grant to a non-employee director, a common practice to compensate board members. Because the option was fully vested and exercisable on grant, the director could exercise it immediately, but the Form 4 does not show an exercise or any sale of underlying shares. Such awards are routine and do not by themselves indicate a personal market-driven purchase or sale.
Insider Transaction Report
- Award
Option to purchase common stock
[F1][F2]2026-06-30+250→ 250 totalExercise: $4.88From: 2026-06-30Exp: 2036-06-30→ Common Stock (250 underlying)
Footnotes (2)
- [F1]The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.
- [F2]In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."